symplr acquires Midas Health Analytics Solutions for $ 340 million –


What you should know:

symplr, a global leader in enterprise health operations, including government SaaS solutions, risk management and compliance (“GRC”), has announced that it has accepted acquire Conduent Incorporated’s Midas Health Analytics Solutions (“Midas”) for $ 340 million. The transaction is expected to close in the first quarter of 2022, subject to the satisfaction of the usual closing conditions and regulatory approvals.

– The acquisition highlights Symplr’s aggressive mergers and acquisitions strategy and the explosive growth of recent years, acquiring 14 companies over a six-year period. symplr, which has the support of Clearlake and Charlesbank Capital, has increased its valuation by ten since 2018, bringing the company to the multimillion-dollar field. Symplr’s SaaS solutions, used by more than 3,000 customers and more than 5 million healthcare professionals, aim to unify the traditional nature of healthcare operations.

Robust Midas data warehouse

Midas Health Analytics Solutions leverages a robust data warehouse with more than 100 million claims and more than 30,000 indicators, as well as comparative data from approximately 800 hospitals. Through its clinical and analytical transformation software solutions, Midas offers strategic guidance, tactical plans, and healthcare management interventions to help healthcare clients improve patient health outcomes.

“Midas Health Analytics Solutions provides useful data and insights to help clients in symplr’s healthcare system improve patient care and deliver better results,” said BJ Schaknowski, symplr’s CEO. “With integrated quality results and advanced machine learning-based analysis, our combined portfolio of compliance, quality and safety software can better predict patient-specific risks, provide information on population health, and improve and support proactively to the performance of business intelligence to further advance Symplr’s mission to transform healthcare operations. ”

Source link